Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Healthcare Biotechnology
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Another SORT1 targeting peptide developed by China???
View:
Post by LouisW on Sep 12, 2023 9:03pm

Another SORT1 targeting peptide developed by China???

https://patentscope.wipo.int/search/en/detail.jsf;jsessionid=217A34C3B21FD7466B4FC114D3D34894.wapp1nB?docId=WO2023165476&_gid=202336

From my perspective, the potential of PDC targeting SORT1 is well recognized.
Comment by PWIB123 on Sep 12, 2023 9:57pm
Can someone opine as to how this polypeptide differs from TH-1902?
Comment by scarlet1967 on Sep 13, 2023 8:09am
I am not a patent expert but they use a peptide binding to sorrilin, cleavable linker.. I sent the below to Christian so they can look into it. https://patents.google.com/patent/US10946073B2/en
Comment by scarlet1967 on Sep 13, 2023 9:02am
The link is wrong the correct link is sent...
Comment by LouisW on Sep 13, 2023 9:02pm
I'm just curious. Any reply received?
Comment by scarlet1967 on Sep 13, 2023 9:14pm
No, and I don't expect any. They most likely will look into it.
Theratechnologies Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities